Filing Details
- Accession Number:
- 0001493152-22-015080
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2022-05-25 17:28:40
- Reporting Period:
- 2022-05-25
- Accepted Time:
- 2022-05-25 17:28:40
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1861657 | Hillstream Biopharma Inc. | HILS | () | 4 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1360968 | Randy Milby | C/O Hillstream Biopharma, Inc. 1200 Route 22 East, Suite 2000 Bridgewater NJ 08807 | Chief Executive Officer | Yes | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2022-05-25 | 200 | $0.77 | 2,936,739 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2022-05-25 | 800 | $0.79 | 2,937,539 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct | |
| No | 4 | P | Direct |
Billionaire Hedge Funds
